00:50 , Mar 7, 2018 |  BC Innovations  |  Distillery Therapeutics

Neurology

INDICATION: Ataxia Cell culture, fruit fly and mouse studies suggest inhibiting KPNA3 could help treat spinocerebellar ataxia type 3 (SCA3), which is caused by mutant ATXN3 containing polyglutamine repeats that accumulates in the nucleus. In a...